23 Feb Aspect Biosystems
Posted at 18:42h
in
Tamer Mohamed, CEO and Founder
Vancouver, B.C., Canada
(Private)
Aspect Biosystems is a biotechnology company pioneering the development of a novel category of cell-based regenerative medicines designed to restore or supplement biological function and deliver curative therapies for some of the most elusive diseases. Aspect is developing these bioengineered cellular medicines by applying its full-stack tissue therapeutic platform, which integrates proprietary AI-powered bioprinting technology, therapeutic cells, hypoimmune cell engineering, and advanced biomaterials. Aspect is advancing its therapeutic pipeline across multiple endocrine and metabolic diseases, including diabetes and rare endocrine disorders.